NEWS

Bigger and Built to Deliver

In sterile injectable manufacturing, growth isn’t optional, it’s key.

At American Injectables, we believe growth is a catalyst for speed, scale, and smarter partnerships. That’s why we’ve launched a significant expansion of our FDA-approved fill-finish facility. New lines. New capabilities. New possibilities.

Why We’re Expanding Now

American Injectables was founded to deliver what modern pharma needed most: agile timelines, responsive partners, and seamless tech transfers. From day one, we’ve focused on speed, transparency, and flexibility, and this expansion is how we uphold that commitment on a larger scale.

What the Expansion Includes

This isn’t just a floor plan update. It’s a strategic upgrade to deliver more value, faster:

  • Additional aseptic manufacturing lines for syringes and vials
  • Flexible batch sizes from small clinical to large commercial campaigns
  • Expanded formulation and R&D capabilities
  • Commercial-scale inspection, labeling, secondary packaging, and serialization

Every element is designed to accelerate the path from formulation to fill, without compromising sterility, compliance, or quality.

How It Impacts You

For our current and future partners, this expansion means:

  • Shorter lead times
  • Commercial-scale capacity
  • Faster tech transfers and process scale-up
  • End-to-end support from formulation to packaging
  • Dedicated project teams who move fast and communicate clearly

Whether you’re an early-stage innovator or preparing for commercial launch, our upgraded site will give your injectable program the space and speed it deserves.

“We’re not expanding for the sake of size. We’re expanding because our clients need more capacity, speed, and flexibility. And we’re building to deliver exactly that.” — Travis Allen, Board Director

Timeline Snapshot 

  • July 2025 > Construction began
  • August 2025 > Equipment installation underway
  • NOW > Pre-booking capacity and batches for 2026
  • Q4 2025 > Engineering batches can be scheduled
  • Q1 2026 > GMP readiness expected

What’s Next

We’ll be sharing behind-the-scenes progress updates, facility milestones, and interviews with the people behind the buildout. Because this isn’t just an expansion. It’s an upgrade to what a CDMO partnership should be.

Follow us on LinkedIn or click here to get a front-row seat to what we’re building.

Recent Posts

Discover more from American Injectables

Subscribe now to keep reading and get access to the full archive.

Continue reading